156 related articles for article (PubMed ID: 23169439)
1. Synthesis of a new pH-sensitive folate-doxorubicin conjugate and its antitumor activity in vitro.
Ye WL; Teng ZH; Liu DZ; Cui H; Liu M; Cheng Y; Yang TH; Mei QB; Zhou SY
J Pharm Sci; 2013 Feb; 102(2):530-40. PubMed ID: 23169439
[TBL] [Abstract][Full Text] [Related]
2. Enhanced Anti-Tumor Effect of Folate-Targeted FA-AMA-hyd-DOX Conjugate in a Xenograft Model of Human Breast Cancer.
Liao TT; Han JF; Zhang FY; Na R; Ye WL
Molecules; 2021 Nov; 26(23):. PubMed ID: 34885691
[TBL] [Abstract][Full Text] [Related]
3. Anticancer activity of released doxorubicin from a folate-mediated polyelectrolyte complex.
Chiu CC; Lin YT; Sun SL; Sung KH; Wang LF
J Biomater Sci Polym Ed; 2011; 22(11):1487-507. PubMed ID: 20626956
[TBL] [Abstract][Full Text] [Related]
4. Folate-functionalized unimolecular micelles based on a degradable amphiphilic dendrimer-like star polymer for cancer cell-targeted drug delivery.
Cao W; Zhou J; Mann A; Wang Y; Zhu L
Biomacromolecules; 2011 Jul; 12(7):2697-707. PubMed ID: 21619062
[TBL] [Abstract][Full Text] [Related]
5. Cellular uptake and antitumor activity of DOX-hyd-PEG-FA nanoparticles.
Ye WL; Du JB; Zhang BL; Na R; Song YF; Mei QB; Zhao MG; Zhou SY
PLoS One; 2014; 9(5):e97358. PubMed ID: 24828815
[TBL] [Abstract][Full Text] [Related]
6. Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery.
Zhang C; Zhao L; Dong Y; Zhang X; Lin J; Chen Z
Eur J Pharm Biopharm; 2010 Sep; 76(1):10-6. PubMed ID: 20472060
[TBL] [Abstract][Full Text] [Related]
7. Folate/N-acetyl glucosamine conjugated mesoporous silica nanoparticles for targeting breast cancer cells: A comparative study.
Kumar P; Tambe P; Paknikar KM; Gajbhiye V
Colloids Surf B Biointerfaces; 2017 Aug; 156():203-212. PubMed ID: 28531877
[TBL] [Abstract][Full Text] [Related]
8. Folate-decorated maleilated pullulan-doxorubicin conjugate for active tumor-targeted drug delivery.
Zhang H; Li F; Yi J; Gu C; Fan L; Qiao Y; Tao Y; Cheng C; Wu H
Eur J Pharm Sci; 2011 Apr; 42(5):517-26. PubMed ID: 21352909
[TBL] [Abstract][Full Text] [Related]
9. Novel folated and non-folated pullulan bioconjugates for anticancer drug delivery.
Scomparin A; Salmaso S; Bersani S; Satchi-Fainaro R; Caliceti P
Eur J Pharm Sci; 2011 Apr; 42(5):547-58. PubMed ID: 21371555
[TBL] [Abstract][Full Text] [Related]
10. Folate-modified poly(2-ethyl-2-oxazoline) as hydrophilic corona in polymeric micelles for enhanced intracellular doxorubicin delivery.
Qiu LY; Yan L; Zhang L; Jin YM; Zhao QH
Int J Pharm; 2013 Nov; 456(2):315-24. PubMed ID: 24016742
[TBL] [Abstract][Full Text] [Related]
11. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
[TBL] [Abstract][Full Text] [Related]
12. Development of surface functionalized hydroxyapatite nanoparticles for enhanced specificity towards tumor cells.
Verma G; Shetake NG; Pandrekar S; Pandey BN; Hassan PA; Priyadarsini KI
Eur J Pharm Sci; 2020 Mar; 144():105206. PubMed ID: 31870813
[TBL] [Abstract][Full Text] [Related]
13. Design and evaluation of folate-appended α-, β-, and γ-cyclodextrins having a caproic acid as a tumor selective antitumor drug carrier in vitro and in vivo.
Okamatsu A; Motoyama K; Onodera R; Higashi T; Koshigoe T; Shimada Y; Hattori K; Takeuchi T; Arima H
Biomacromolecules; 2013 Dec; 14(12):4420-8. PubMed ID: 24175976
[TBL] [Abstract][Full Text] [Related]
14. Characterization and evaluation of a folic acid receptor-targeted cyclodextrin complex as an anticancer drug delivery system.
Xu J; Xu B; Shou D; Qin F; Xu Y; Hu Y
Eur J Pharm Sci; 2016 Feb; 83():132-42. PubMed ID: 26577995
[TBL] [Abstract][Full Text] [Related]
15. Improved drug targeting of cancer cells by utilizing actively targetable folic acid-conjugated albumin nanospheres.
Shen Z; Li Y; Kohama K; Oneill B; Bi J
Pharmacol Res; 2011 Jan; 63(1):51-8. PubMed ID: 21035550
[TBL] [Abstract][Full Text] [Related]
16. Active Drug Targeting of a Folate-Based Cyclodextrin-Doxorubicin Conjugate and the Cytotoxic Effect on Drug-Resistant Mammary Tumor Cells In Vitro.
Mizusako H; Tagami T; Hattori K; Ozeki T
J Pharm Sci; 2015 Sep; 104(9):2934-40. PubMed ID: 25940848
[TBL] [Abstract][Full Text] [Related]
17. Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance.
Fan L; Li F; Zhang H; Wang Y; Cheng C; Li X; Gu CH; Yang Q; Wu H; Zhang S
Biomaterials; 2010 Jul; 31(21):5634-42. PubMed ID: 20430433
[TBL] [Abstract][Full Text] [Related]
18. Multifunctional stable and pH-responsive polymer vesicles formed by heterofunctional triblock copolymer for targeted anticancer drug delivery and ultrasensitive MR imaging.
Yang X; Grailer JJ; Rowland IJ; Javadi A; Hurley SA; Matson VZ; Steeber DA; Gong S
ACS Nano; 2010 Nov; 4(11):6805-17. PubMed ID: 20958084
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of novel folic acid receptor-targeted, β-cyclodextrin-based drug complexes for cancer treatment.
Yin JJ; Sharma S; Shumyak SP; Wang ZX; Zhou ZW; Zhang Y; Guo P; Li CZ; Kanwar JR; Yang T; Mohapatra SS; Liu W; Duan W; Wang JC; Li Q; Zhang X; Tan J; Jia L; Liang J; Wei MQ; Li X; Zhou SF
PLoS One; 2013; 8(5):e62289. PubMed ID: 23658721
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin loaded silica nanorattles actively seek tumors with improved anti-tumor effects.
Gao F; Li L; Liu T; Hao N; Liu H; Tan L; Li H; Huang X; Peng B; Yan C; Yang L; Wu X; Chen D; Tang F
Nanoscale; 2012 Jun; 4(11):3365-72. PubMed ID: 22538830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]